Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery

NCT07186660 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT07186660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07186660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Recruiting
Start date
February 22, 2026
Completion date
September 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular health, glycemic control for diabetes mellitus, insulin, ketones, type 1 diabetes (t1d)